Measuring unadulterated whole blood viscosity in patients with familial hypercholesterolemia on long-term LDL apheresis

被引：0
|
作者：
Moriarty, PM
Gibson, CA
Kensey, KR
Hogenauer, WN
机构：
[1] Univ Kansas, Sch Med, Kansas City, KS USA
[2] Rheol Inc, Exton, PA USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2002年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P269
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [31] LONG-TERM TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA WITH HEPARIN-INDUCED EXTRACORPOREAL LDL PRECIPITATION
    ROTH, R
    KOSTER, W
    WANNER, C
    ANDRE, M
    ORTH, M
    WIELAND, H
    SCHOLLMEYER, P
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (30) : 1135 - 1141
  • [32] LOW-DENSITY-LIPOPROTEIN APHERESIS AS LONG-TERM TREATMENT FOR CHILDREN WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    ZWIENER, RJ
    UAUY, R
    PETRUSKA, ML
    HUET, BA
    JOURNAL OF PEDIATRICS, 1995, 126 (05): : 728 - 735
  • [33] Long-term efficacy of low density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
    Mabuchi, H
    Koizumi, J
    Shimizu, M
    Kajinami, K
    Miyamoto, S
    Ueda, K
    Takegoshi, T
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (12): : 1489 - 1495
  • [34] THE EFFECT OF LDL APHERESIS ON PROGRESSION OF CORONARY-ARTERY-DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA - RESULTS OF A MULTICENTER LDL APHERESIS STUDY
    WAIDNER, T
    FRANZEN, D
    VOELKER, W
    RITTER, M
    BORBERG, H
    HOMBACH, V
    HOPP, HW
    CLINICAL INVESTIGATOR, 1994, 72 (11): : 858 - 863
  • [35] Direct adsorption of lipoproteins (DALI) from whole blood:: First long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia
    Jansen, M
    Banyai, S
    Schmaldienst, S
    Goldammer, A
    Rohac, M
    Hörl, WH
    Derfler, K
    WIENER KLINISCHE WOCHENSCHRIFT, 2000, 112 (02) : 61 - 69
  • [36] SELECTIVE LDL APHERESIS DECREASES SERUM CHEMERIN LEVELS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Harangi, M.
    Varga, V. E.
    Lorincz, H.
    Zsiros, N.
    Seres, I.
    Fueloep, P.
    Balla, J.
    Paragh, G.
    ATHEROSCLEROSIS, 2015, 241 (01) : E205 - E205
  • [37] COMBINATION THERAPY OF EVOLOCUMAB AND LDL APHERESIS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: A CASE SERIES
    Alarcon Garcia, Jose Carlos
    Gonzalez Estrada, Aurora
    Camacho Carrasco, Ana
    Garcia Ocana, Paula
    Alarcon Garcelan, Maria Carmen
    Espinosa-Torre, Fatima
    Alfaro-Lara, Veronica
    Muniz Grijalvo, Ovidio
    ATHEROSCLEROSIS, 2017, 263 : E230 - E230
  • [38] LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia
    Nenseter, Marit S.
    Bogsrud, Martin P.
    Graesdal, Asgeir
    Narverud, Ingunn
    Halvorsen, Bente
    Ose, Leiv
    Aukrust, Pal
    Holven, Kirsten B.
    THROMBOSIS RESEARCH, 2012, 130 (05) : 823 - 825
  • [39] Safety and effectiveness of long-term LDL-apheresis in patients at high risk
    Thiery, J
    Seidel, D
    CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (06) : 521 - 526
  • [40] EFFECTS OF LONG-TERM LDL-C LOWERING ON ATHEROSCLEROSIS IN ADULTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Sivapalaratnam, S.
    van Loendersloot, L.
    Hutten, B.
    Trip, M.
    Kastelein, J.
    de Groot, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
12345